share_log

SVB Securities Adjusts Pardes Biosciences' Price Target to $9 From $12, Keeps Outperform Rating

SVB Securities Adjusts Pardes Biosciences' Price Target to $9 From $12, Keeps Outperform Rating

SVB 證券將帕德生物科學的目標價格從 12 美元調整至 9 美元,保持「跑贏大市」評級
MT Newswires ·  2023/01/27 10:47

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論